Beyond Air, Inc. (XAIR)
USD 0.22
(-8.94%)
USD 0.22
(-8.94%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 29.77 Million USD | 11.43% |
| 2023 | 26.72 Million USD | 27.3% |
| 2022 | 20.99 Million USD | 108.61% |
| 2021 | 10.06 Million USD | 7.7% |
| 2020 | 9.34 Million USD | 72.9% |
| 2019 | 5.4 Million USD | -30.82% |
| 2018 | 7.81 Million USD | 58.31% |
| 2017 | 4.93 Million USD | 15762.91% |
| 2016 | 31.1 Thousand USD | 210.79% |
| 2015 | 10 Thousand USD | -97.65% |
| 2014 | 425 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 29.77 Million USD | 11.43% |
| 2024 Q1 | 33.9 Million USD | 26.87% |
| 2024 Q2 | 29.17 Million USD | -13.94% |
| 2024 Q3 | 28.43 Million USD | -2.52% |
| 2024 Q4 | 29.77 Million USD | 4.7% |
| 2023 FY | 26.72 Million USD | 27.3% |
| 2023 Q2 | 18.38 Million USD | -10.54% |
| 2023 Q3 | 18.51 Million USD | 0.72% |
| 2023 Q4 | 26.72 Million USD | 44.29% |
| 2023 Q1 | 20.55 Million USD | -2.08% |
| 2022 Q2 | 13.13 Million USD | 22.54% |
| 2022 Q4 | 20.99 Million USD | 145.78% |
| 2022 FY | 20.99 Million USD | 108.61% |
| 2022 Q1 | 10.71 Million USD | 6.53% |
| 2022 Q3 | 8.54 Million USD | -34.98% |
| 2021 Q2 | 8.34 Million USD | -3.39% |
| 2021 Q3 | 7.6 Million USD | -8.81% |
| 2021 Q4 | 10.06 Million USD | 32.27% |
| 2021 FY | 10.06 Million USD | 7.7% |
| 2021 Q1 | 8.63 Million USD | -7.58% |
| 2020 Q2 | 5.62 Million USD | 6.91% |
| 2020 FY | 9.34 Million USD | 72.9% |
| 2020 Q4 | 9.34 Million USD | 97.07% |
| 2020 Q3 | 4.74 Million USD | -15.7% |
| 2020 Q1 | 5.26 Million USD | -2.65% |
| 2019 Q3 | 1.45 Million USD | -85.85% |
| 2019 Q4 | 5.4 Million USD | 271.78% |
| 2019 Q1 | 8.47 Million USD | 8.45% |
| 2019 FY | 5.4 Million USD | -30.82% |
| 2019 Q2 | 10.27 Million USD | 21.28% |
| 2018 Q4 | 7.81 Million USD | -26.1% |
| 2018 Q3 | 10.56 Million USD | -3.44% |
| 2018 FY | 7.81 Million USD | 58.31% |
| 2018 Q1 | 5.68 Million USD | -12.96% |
| 2018 Q2 | 10.94 Million USD | 92.69% |
| 2017 Q2 | 37.26 Thousand USD | 19.81% |
| 2017 Q4 | 6.52 Million USD | 32.27% |
| 2017 FY | 4.93 Million USD | 15762.91% |
| 2017 Q1 | 31.1 Thousand USD | 206.17% |
| 2017 Q3 | 4.93 Million USD | 13140.31% |
| 2016 Q3 | 10.1 Thousand USD | 0.0% |
| 2016 Q4 | 10.15 Thousand USD | 0.5% |
| 2016 FY | 31.1 Thousand USD | 210.79% |
| 2016 Q1 | 1.57 Million USD | 0.0% |
| 2016 Q2 | - USD | -100.0% |
| 2015 Q3 | 1.05 Million USD | 0.0% |
| 2015 Q2 | 1.05 Million USD | 0.0% |
| 2015 FY | 10 Thousand USD | -97.65% |
| 2015 Q4 | 1.57 Million USD | 49.72% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | 425 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Envoy Medical, Inc. | 9.4 Million USD | -216.688% |
| OrthoPediatrics Corp. | 72.56 Million USD | 58.966% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -0.656% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -28.707% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -6901.253% |
| PAVmed Inc | 57.13 Million USD | 47.888% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 41.907% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -16.934% |
| RxSight, Inc. | 22.18 Million USD | -34.194% |
| Sight Sciences, Inc. | 46.43 Million USD | 35.879% |
| SI-BONE, Inc. | 61.05 Million USD | 51.229% |
| TELA Bio, Inc. | 59.16 Million USD | 49.676% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 73.874% |
| Bioventus Inc. | 589.79 Million USD | 94.952% |
| BrainsWay Ltd. | 15.31 Million USD | -94.43% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -188.545% |
| CVRx, Inc. | 39.28 Million USD | 24.202% |
| electroCore, Inc. | 8.94 Million USD | -232.868% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -457.376% |
| Inogen, Inc. | 121.38 Million USD | 75.47% |
| IceCure Medical Ltd | 4.24 Million USD | -601.083% |
| Spectral AI, Inc. | 12.4 Million USD | -140.102% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -835.749% |
| MaxCyte, Inc. | 36.1 Million USD | 17.537% |
| Acutus Medical, Inc. | 54.83 Million USD | 45.705% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1125.662% |
| Talis Biomedical Corporation | 29.22 Million USD | -1.885% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1511.28% |
| Orthofix Medical Inc. | 326.58 Million USD | 90.883% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -148.995% |
| Cerus Corporation | 144.3 Million USD | 79.366% |
| Venus Concept Inc. | 107.1 Million USD | 72.2% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 42.367% |
| LivaNova PLC | 1.15 Billion USD | 97.415% |
| 908 Devices Inc. | 37.49 Million USD | 20.579% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 95.768% |
| Nemaura Medical Inc. | 26.37 Million USD | -12.881% |
| NeuroPace, Inc. | 86.99 Million USD | 65.775% |
| LENSAR, Inc. | 22.4 Million USD | -32.871% |
| Apyx Medical Corporation | 52.31 Million USD | 43.088% |
| Cutera, Inc. | 518.12 Million USD | 94.253% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -1.524% |
| BioSig Technologies, Inc. | 4.68 Million USD | -535.539% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 48.987% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -38.566% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.643% |
| Axonics, Inc. | 82.35 Million USD | 63.847% |
| Outset Medical, Inc. | 190.91 Million USD | 84.404% |
| IRIDEX Corporation | 24.91 Million USD | -19.511% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 75.981% |
| IRadimed Corporation | 20.73 Million USD | -43.591% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1678.674% |
| INVO Bioscience, Inc. | 19.99 Million USD | -48.913% |
| Telesis Bio, Inc. | 40.87 Million USD | 27.152% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 27.005% |
| Varex Imaging Corporation | 668.6 Million USD | 95.547% |
| Quipt Home Medical Corp. | 136.29 Million USD | 78.154% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -733.567% |
| Pulmonx Corporation | 60.63 Million USD | 50.896% |
| Dynatronics Corporation | 11.78 Million USD | -152.756% |
| Modular Medical, Inc. | 2.27 Million USD | -1210.519% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -632.653% |
| Semler Scientific, Inc. | 6.27 Million USD | -374.88% |
| InMode Ltd. | 75.91 Million USD | 60.778% |
| Bruker Corporation | 2.83 Billion USD | 98.95% |
| Cytosorbents Corporation | 29.98 Million USD | 0.702% |
| DexCom, Inc. | 4.19 Billion USD | 99.29% |
| Align Technology, Inc. | 2.45 Billion USD | 98.786% |
| Viveve Medical, Inc. | 10.84 Million USD | -174.5% |
| ZimVie Inc. | 795.85 Million USD | 96.259% |
| Movano Inc. | 5.97 Million USD | -398.577% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 71.536% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -6901.253% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -148.995% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 95.341% |
| Profound Medical Corp. | 12.66 Million USD | -135.081% |
| Insulet Corporation | 1.85 Billion USD | 98.395% |
| enVVeno Medical Corporation | 2.43 Million USD | -1122.793% |
| Surmodics, Inc. | 65.82 Million USD | 54.765% |
| iCAD, Inc. | 8 Million USD | -272.141% |
| Nuwellis, Inc. | 6.78 Million USD | -339.159% |
| Biotricity, Inc. | 35.91 Million USD | 17.106% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 86.651% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1100.774% |
| InspireMD, Inc. | 8.14 Million USD | -265.696% |
| PAVmed Inc. | 57.13 Million USD | 47.888% |
| BIOLASE, Inc. | 35.34 Million USD | 15.766% |
| FONAR Corporation | 57.45 Million USD | 48.179% |
| AxoGen, Inc. | 101.16 Million USD | 70.567% |
| Vivani Medical, Inc. | 25.03 Million USD | -18.929% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 66.086% |
| Inari Medical, Inc. | 209.32 Million USD | 85.776% |
| UFP Technologies, Inc. | 118.04 Million USD | 74.777% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -134.624% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1262.194% |
| Tenon Medical, Inc. | 5.56 Million USD | -434.848% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1573.693% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -68.849% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.056% |
| Sintx Technologies, Inc. | 6.59 Million USD | -351.615% |
| NanoVibronix, Inc. | 2.68 Million USD | -1008.526% |
| Quanterix Corporation | 78.08 Million USD | 61.868% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -733.567% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -509.519% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 97.15% |
| TransMedics Group, Inc. | 568.84 Million USD | 94.766% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -78.486% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2133.476% |
| Hyperfine, Inc. | 9.8 Million USD | -203.827% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 88.102% |
| Biomerica, Inc. | 2.66 Million USD | -1018.1% |
| Bone Biologics Corporation | 831.4 Thousand USD | -3481.3% |
| AVITA Medical, Inc. | 19.86 Million USD | -49.884% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1408.601% |
| Silk Road Medical, Inc | 114.15 Million USD | 73.918% |